Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Prescription Channel Dominates Nutritional Distribution The Rx segment held 68.5% of industry share in 2024 and is projected to grow to 72% in 2025
Slow your weight loss pace if possible
(PubMed) Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L
Recent head-to-head clinical trials have directly compared tirzepatide (e.g., Zepbound) to semaglutide (e.g., Wegovy) for weight loss in individuals with obesity but without diabetes
Personalized dosing via telehealth or in-office
US$ 21.87
US$ 20.60
US$ 24.62
US$ 28.06
US$ 22.29
US$ 20.39
US$ 20.99
US$ 23.98
US$ 27.39
US$ 29.95
US$ 23.76
US$ 21.97
